Research and discoveries

Find a researcher

ICR divisions

Centres and strategic collaborations

Our facilities and technology

Research by cancer type

Cancer discovery news

Cancer blogs

Animal research

Our research achievements

ICR divisions Breast Cancer Research Cancer Biology Cancer Therapeutics Cell and Molecular Biology Clinical Studies Genetics and Epidemiology Radiotherapy and Imaging Structural Biology

Our facilities and technology Baculovirus Facility Light Microscopy Facility Electron Microscopy Facility Flow Cytometry Facility Mechanical Workshop and 3D Printing Proteomics Core Facility Scientific Computing Service Genomics Facility X-ray Crystallography Facility Chelsea Biophysics Facility Correlative Light and Electron Microscopy (CLEM) Lab Antibody Facility

Research by cancer type Bladder cancer Blood cancers Bone cancer Bowel cancer Brain cancer Breast cancer Cervical cancer Childhood cancers Gastrointestinal cancers Head and neck cancer Kidney cancer Lung cancer Melanoma Ovarian cancer Pancreatic cancer Prostate cancer Sarcoma

Cancer blogs Research blogs The Darwin Cancer Blog

Our research achievements Characterising the BRAF gene Transforming prostate cancer treatment Advanced radiotherapy techniques Identifying a breast cancer gene Targeting Hsp90 How cells become cancerous The function of the thymus Practice changing clinical trials in radiotherapy and imaging DNA damage and cancer Identifying cancer predisposition genes Applying evolutionary biology to cancer Transforming treatment for the most common type of breast cancer Developing the Pharmacological Audit Trail Discovering early chemotherapy drugs Discovering and developing a leading PI3K inhibitor Applying genetic principles to treatment of BRCA-mutant cancers Carcinogens in cigarette smoke

Study and careers

PhDs for science graduates

Opportunities for clinicians

Student life and support

Undergraduate Summer Scholarship Scheme

Support moving to the UK

Careers at the ICR

Working life and benefits

PhDs for science graduates Our PhD projects Our PhD application process Black Leaders in Cancer & Convergence PhD Studentships PhD FAQs and funding Contact student admissions PhDs and training news

Opportunities for clinicians MSc in Oncology PhD and MD(Res) for clinicians NIHR academic training Radiotherapy and imaging training courses Opportunities for postdoctoral clinical fellows

Student life and support Tuition fees Accommodation support Welfare Social life Academic and career support Student resources Student stories Alumni stories

Undergraduate Summer Scholarship Scheme How to apply FAQs Research groups

Careers at the ICR Postdocs Research scientists and scientific support Group leaders Clinicians Professional Service roles Contact our career faculty Apprenticeships

Working life and benefits Staff benefits World-leading working facilities Equality and social groups Career development Employee stories

Industry partnerships

Partnership opportunities

Consultancy in oncology

Why partner with us

Our therapeutic pipeline

London Cancer Hub

Contact our partner team

Why partner with us Our partnership philosophy The Innovation Gateway Entrepreneurs-in-residence Spin-out companies Enterprise events Our treatment and technology successes

About us

Our strategy

Our history

Leadership and governance

ICR and The Royal Marsden

ICR news

Patient stories

Public engagement and schools outreach

Advocacy engagement: policy and public affairs

Funding and spending

Reports and policies

Contact us

Our strategy Strategic partners Our values Equality and diversity Sustainability

Leadership and governance Our leadership team Executive board Board of trustees Corporate governance ICR committees

Public engagement and schools outreach Resources for schools Public engagement strategy Public events Our Engagement Stories

Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research Joining up the clinical research pipeline

Reports and policies Annual reports Improving access to clinical trials Improving drug access Use of biomarkers in cancer research and treatment Freedom of speech Annual report on bullying and harassment

Support us

Making a donation

Fundraising

Leave a legacy

Philanthropy

Corporate partnerships

Charity partners

Our appeals

Search newsletter

Making a donation Why donate to the ICR How is my money spent Contact our donations team Payroll giving Gift Aid

Fundraising How to fundraise with us Sport events and challenges Fundraising news Supporter stories Share your story Volunteer at our events

Leave a legacy Create a Will for free Donate in memory Information for executors The National Free Wills Network Meet our Legacy Marketing Officers

Charity partners Rob's ARTT Siobhan's Superstar Legacy

Our appeals Help every man with prostate cancer Help us outsmart melanoma Defeat blood cancer Help more women survive cancer Childhood cancers Combination treatments Monthly gift for cancer patients

Search:

Research and discoveries

Study and careers

Industry partnerships

About us

Support us

See all hubs

Research and discoveries

Find a researcher

ICR divisions

Centres and strategic collaborations

Our facilities and technology

Research by cancer type

Cancer discovery news

Cancer blogs

Animal research

Our research achievements

See all hubs

Study and careers

PhDs for science graduates

Opportunities for clinicians

Student life and support

Undergraduate Summer Scholarship Scheme

Support moving to the UK

Careers at the ICR

Working life and benefits

See all hubs

Industry partnerships

Partnership opportunities

Consultancy in oncology

Why partner with us

Our therapeutic pipeline

London Cancer Hub

Contact our partner team

See all hubs

About us

Our strategy

Our history

Leadership and governance

ICR and The Royal Marsden

ICR news

Patient stories

Public engagement and schools outreach

Advocacy engagement: policy and public affairs

Funding and spending

Reports and policies

Contact us

See all hubs

Support us

Making a donation

Fundraising

Leave a legacy

Philanthropy

Corporate partnerships

Charity partners

Our appeals

Search newsletter

See Research and discoveries

Find a researcher

Publications

See Research and discoveries

ICR divisions

Breast Cancer Research

Cancer Biology

Cancer Therapeutics

Cell and Molecular Biology

Clinical Studies

Genetics and Epidemiology

Radiotherapy and Imaging

Structural Biology

See Research and discoveries

Our facilities and technology

Baculovirus Facility

Light Microscopy Facility

Electron Microscopy Facility

Flow Cytometry Facility

Mechanical Workshop and 3D Printing

Proteomics Core Facility

Scientific Computing Service

Genomics Facility

X-ray Crystallography Facility

Chelsea Biophysics Facility

Correlative Light and Electron Microscopy (CLEM) Lab

Antibody Facility

See Research and discoveries

Research by cancer type

Bladder cancer

Blood cancers

Bone cancer

Bowel cancer

Brain cancer

Breast cancer

Cervical cancer

Childhood cancers

Gastrointestinal cancers

Head and neck cancer

Kidney cancer

Lung cancer

Melanoma

Ovarian cancer

Pancreatic cancer

Prostate cancer

Sarcoma

See Research and discoveries

Cancer discovery news

Media office

See Research and discoveries

Cancer blogs

Research blogs

The Darwin Cancer Blog

See Research and discoveries

Our research achievements

Characterising the BRAF gene

Transforming prostate cancer treatment

Advanced radiotherapy techniques

Identifying a breast cancer gene

Targeting Hsp90

How cells become cancerous

The function of the thymus

Practice changing clinical trials in radiotherapy and imaging

DNA damage and cancer

Identifying cancer predisposition genes

Applying evolutionary biology to cancer

Transforming treatment for the most common type of breast cancer

Developing the Pharmacological Audit Trail

Discovering early chemotherapy drugs

Discovering and developing a leading PI3K inhibitor

Applying genetic principles to treatment of BRCA-mutant cancers

Carcinogens in cigarette smoke

See Study and careers

PhDs for science graduates

Our PhD projects

Our PhD application process

Black Leaders in Cancer & Convergence PhD Studentships

PhD FAQs and funding

Contact student admissions

PhDs and training news

See Study and careers

Opportunities for clinicians

MSc in Oncology

PhD and MD(Res) for clinicians

NIHR academic training

Radiotherapy and imaging training courses

Opportunities for postdoctoral clinical fellows

See Study and careers

Student life and support

Tuition fees

Accommodation support

Welfare

Social life

Academic and career support

Student resources

Student stories

Alumni stories

See Study and careers

Undergraduate Summer Scholarship Scheme

How to apply

FAQs

Research groups

See Study and careers

Careers at the ICR

Postdocs

Research scientists and scientific support

Group leaders

Clinicians

Professional Service roles

Contact our career faculty

Apprenticeships

See Study and careers

Working life and benefits

Staff benefits

World-leading working facilities

Equality and social groups

Career development

Employee stories

See Industry partnerships

Why partner with us

Our partnership philosophy

The Innovation Gateway

Entrepreneurs-in-residence

Spin-out companies

Enterprise events

Our treatment and technology successes

See Industry partnerships

Contact our partner team

Connections newsletter

See About us

Our strategy

Strategic partners

Our values

Equality and diversity

Sustainability

See About us

Leadership and governance

Our leadership team

Executive board

Board of trustees

Corporate governance

ICR committees

See About us

Public engagement and schools outreach

Resources for schools

Public engagement strategy

Public events

Our Engagement Stories

See About us

Advocacy engagement: policy and public affairs

Our policy priorities

Creating a sustainable funding model for research in universities

Encouraging international talent to support cancer research

Joining up the clinical research pipeline

See About us

Reports and policies

Annual reports

Improving access to clinical trials

Improving drug access

Use of biomarkers in cancer research and treatment

Freedom of speech

Annual report on bullying and harassment

See Support us

Making a donation

Why donate to the ICR

How is my money spent

Contact our donations team

Payroll giving

Gift Aid

See Support us

Fundraising

How to fundraise with us

Sport events and challenges

Fundraising news

Supporter stories

Share your story

Volunteer at our events

See Support us

Leave a legacy

Create a Will for free

Donate in memory

Information for executors

The National Free Wills Network

Meet our Legacy Marketing Officers

See Support us

Philanthropy

Our philanthropic activity

See Support us

Corporate partnerships

Corporate partnership highlights

See Support us

Charity partners

Rob's ARTT

Siobhan's Superstar Legacy

See Support us

Our appeals

Help every man with prostate cancer

Help us outsmart melanoma

Defeat blood cancer

Help more women survive cancer

Childhood cancers

Combination treatments

Monthly gift for cancer patients

Meg Dinesh Kumar

Higher Scientific Officer: Molecular Cell Biology

Email: [email protected]

Location: Chelsea

Anonymous

Email: [email protected]

Location: Chelsea

Home
Research and discoveries
Find a researcher

Related pages

Breast Cancer Research
Molecular Cell Biology

inpartnershipwith

Research and discoveries
Study and careers
Industry partnerships
About us
Support us

Contact us
Privacy
Terms and conditions
Accessibility
Purchasing
Conflict of interest in research
Annual remuneration statement
Sustainability
Modern slavery statement
Cookies

Copyright © 2025 The Institute of Cancer Research.

All rights reserved. Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP. A Charity, Not for Profit. Company Limited by Guarantee.
Registered in England No. 534147. VAT Registration No. GB 849 0581 02.